Etilefrine

From WikiMD's WELLNESSPEDIA

(Redirected from Effortil)


Etilefrine is a cardiovascular drug, specifically a cardiac stimulant used in the treatment of hypotension. It is classified as a sympathomimetic amine, a type of drug that mimics the actions of the sympathetic nervous system.

Pharmacology[edit]

Etilefrine acts primarily on alpha-1 and beta adrenergic receptors, leading to an increase in blood pressure and heart rate. It is a direct-acting sympathomimetic, meaning it directly stimulates these receptors without the need for the body's natural neurotransmitter, norepinephrine.

Medical Uses[edit]

Etilefrine is used in the treatment of hypotension, a condition characterized by abnormally low blood pressure. It can be used in both acute and chronic cases, and is particularly useful in treating orthostatic hypotension, a type of low blood pressure that occurs when standing up from a sitting or lying position.

Side Effects[edit]

As with all medications, etilefrine can cause side effects. These may include palpitations, tachycardia (rapid heart rate), hypertension (high blood pressure), and angina pectoris (chest pain).

Contraindications[edit]

Etilefrine should not be used in patients with hypertrophic cardiomyopathy, a condition characterized by thickening of the heart muscle, as it can exacerbate the symptoms. It is also contraindicated in patients with pheochromocytoma, a rare tumor of the adrenal glands that can cause high blood pressure.

See Also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.